edap  stock quote for edap tms sa  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices edap tms sa nasdaq edap us markets close in min adchoices     after hours     july    pm edt bats bzx realtime last price currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg k k days range  wk range  market cap m dividend rate  yield  beta  shares outstanding m pe ratio eps   recent news stryker poised on solid product portfolio and acquisitions zacks equity research accurays q preliminary results fail to cheer investors zacks equity research accurays medical systems to be acquired by dubai hospital zacks equity research becton dickinson bdx poised on cr bard acquisition zacks equity research mazor expects higher q revenues wins mazor x orders zacks equity research envision healthcare rallies on infinity healthcare buyout zacks equity research patterson companies grapples with multiple issues dump now zacks equity research varian halcyon system gets k approval from the fda zacks equity research luminex gets ce mark for aries norovirus assay shares rally zacks equity research edap tms edap shares march higher can it continue zacks equity research teladoc tdoc to raise debt for best doctors acquisition zacks equity research  stocks moving in wednesdays premarket session benzinga teladoc tdoc to buy best doctors stock hits new high zacks equity research universal health grows on acquisitions rising debt a drag zacks equity research looking for a top momentum stock  reasons why edap tms edap is a great choice zacks equity research edap tms edap shows strength stock adds  in session zacks equity research new strong buy stocks for june th zacks equity research adchoices adchoices adchoices markets dow dow ▼    last updated time   pm edt markets nasdaq nasdaq ▲    ftse  ftse  ▼    nyse composite nyse composite ▼    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support edap tms  global leader in therapeutic ultrasound we use cookies to ensure that we give you the best experience on our website if you continue without changing your browser settings we will assume that you are agree to receive all cookies on this website continue ablatherm robotic hifu is now available in the us read more high intensity focused ultrasound focal one® focal one® brings the answer to all requirements for ideal focal therapy accurate and mrfused imaging noninvasive surgical approach precise and efficient therapeutic energy and endoftreatment validation imaging eswl by edap tms visiotrack stereotactic lithotripsy freeline ultrasound localization system a userfriendly system to guarantee the best treatment efficacy available on the sonolith® product range news may   edap announces cms approval of new reimbursement code for hifu ablation of the prostate read more feb   edaps ablatherm® robotic hifu treatments performed at university of minnesota read more jan   edap to exclusively distribute labories medical measurement systems urodynamic products in japan read more high intensity focused ultrasound hifu for prostate cancer as an alternative to standard radical therapies such as surgery and radiotherapy edap tms offers a noninvasive treatment based on high intensity focused ultrasound hifu eswl and stone laser stone management as a world leader in extracorporeal lithotripsy for more than  years edap tms offers a complete range of noninvasive and minimally invasive solutions covering the full scope of urinary tract stone indications      hemiablation prospective multicentric study of  patients now published in european urology journal link   hifu prostate website was set up to provide patients with useful information relating to prostate cancer treatments and particularly on hifu treatmentlink   products  services we use cookies to ensure that we give you the best experience on our website if you continue without changing your browser settings we will assume that you are agree to receive all cookies on this website continue home   products  services       products  services high intensity focused ultrasound hifu for prostate cancer as an alternative to standard radical therapies such as surgery and radiotherapy edap tms offers a noninvasive treatment based on high intensity focused ultrasound hifu eswl and stone laser stone management as a world leader in extracorporeal lithotripsy for more than  years edap tms offers a complete range of noninvasive and minimally invasive solutions covering the full scope of urinary tract stone indications hifu and eswl users services edap tms is a serviceoriented company providing fitted services to hifu and eswl users the company tailors purchase mobile and alacarte services to address the needs of all hospitals whatever their size and location edap tms is constantly innovating to bring reliable hightech safe userfriendly and minimallyinvasive therapeutic ultrasound solutions edap tms believes that service is part of the device and the company has designed special services to add value to its devices and to be at the users side at all stagesusing the latest it and communication and technologies edap tms is able to provide realtime service worldwide hifu can be subject to local regulations for more information please contact us investors information  edap tms sa home    investors information investors information edap tms is presently accelerating adoption of hifu therapy as a new standard of care for localized prostate cancer in europe where the company is the clear market leader while securing us approval through an active fda clinical study at leading urology centers nasdaq edap     day high  day low   volume      pm et on jul   delayed  min by esignal intra  mo  mo  yr press releases jul   edap to host webcast discussing hifu devices with an american key opinion leader jul   edap announces withdrawal of k application for focal one® to be followed by new submission to conform to fda review rules view all press releases events  presentations jul   at  pm et edaptms nasdaq edap webcast may   at  am et edap first quarter  results conference call view all events  presentations briefcase briefcase printed materials printed materials email alerts email alerts downloads downloads snapshot snapshot rss rss print print share share facebook google linkedin twitter email rss search search ablatherm hifu we use cookies to ensure that we give you the best experience on our website if you continue without changing your browser settings we will assume that you are agree to receive all cookies on this website continue home   products  services   prostate cancer   ablatherm hifu  ablatherm hifu noninvasive treatment for prostate cancer the ablatherm® hifu device has been developed since  for the radical treatment of localized prostate cancer it is suitable for men who are at risk for surgery due to their age or other associated illnesses or who may not want to undergo surgery it may also be suitable for men with cancer has recurrence following radiotherapy description treatment benefits video brochure description the robotic hifu device two modules one probe a treatment module a control module a probe with both treatment and imaging transducers hifu technology unitary lesion of  to  mm height per  mm width automatic dispatching of the hifu lesions precise destruction of the tissue precise robotic movements realtime tracking and adjustment of energy delivered safety features rectal cooling patient movement detection real time rectal wall monitoring treatment minimallyinvasive therapy for prostate cancers patient installation after a local or general anaesthetic is administered the patient lies down on his right hand side right lateral decubitus and stays in this position throughout the treatment three phases treatment patients undergoing ablatherm® hifu treatment are given a general or spinal anesthetic a probe is introduced in the rectum and the imaging transducer starts the gland scanning to plan the treatment the treatment transducer then emits high intensity focused ultrasound in the prostate gland at the point where the ultrasound waves are focused the absorption of the ultrasound beam creates a sudden temperature increase around °c which destroys the tissue in the targeted zone d imaging d imaging of the prostate with mhz transducer treatment planning fully adjustable treatment parameters to suit all prostate anatomies robotic treatment robotic treatment of the prostate following the treatment plan benefits technological innovations for a better patients management hifu benefits noninvasive  radiation free precise robotic treatment preservation of surrounding tissue different treatment strategies whole gland  nerve sparing  hemiablation quality of life preservation short hospital stay short recovery time few side effects video ablatherm hifu video video is not visible most likely your browser does not support html video please fill out the form to know more about ablatherm hifu® device name  country  email  subject  message  website  cancel contact us brochure ablatherm hifu brochure please fill out the contact form to retrieve the ablatherm hifu brochure in the united states ablatherm® hifu is indicated for the ablation of prostate tissue hifu can be subject to local regulations for more information please contact us mentions légales à la destination des professionnels de santé français lablatherm® hifu est fabriqué par edap tms ce dispositif médical est un produit de santé réglementé qui porte au titre de cette réglementation le marquage ce de classe iib son évaluation de conformité a été réalisée par le gmed  lablatherm® hifu est indiqué dans le traitement du cancer localisé de la prostate stade t ou t la destruction par ultrasons focalisés de haute intensité par voie rectale dun adénocarcinome localisé de la prostate est prise en charge forfaitairement selon larrêté du  mai  au titre de larticle l du code de la sécurité sociale dans le cadre du forfait innovation il est conseillé de consulter au préalable le manuel dutilisation      hifu prostate website was set up to provide patients with useful information relating to prostate cancer treatments and particularly on hifu treatmentlink find a treatment centerlink clinical information we use cookies to ensure that we give you the best experience on our website if you continue without changing your browser settings we will assume that you are agree to receive all cookies on this website continue home   clinical information       clinical information prostate cancer management prostate cancer is a major public health concern since  of cancers diagnosed in men are prostate cancers far behind is lung cancer  and rectum cancer    stone management urinary tract stones are frequent and affect  of the worlds population with twice as many men affected than women   edapnasdaq gm stock quote  edap tms sa  bloomberg markets error could not add to watchlist x  watchlist edap tms sa edapus nasdaq gm usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share eur ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry health care equipment  services  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later  edap announces withdrawal of k application for focal one® to be followed by new submission to conform to fda review rules  edap announces cms approval of new reimbursement code for hifu ablation of the prostate  edap tms sa reports first quarter  results  edap announces ablatherm fusion world premiere during american urology association annual meeting in boston ma may   edap tms sa to report first quarter  financial results on may    edap achieves  growth in hifu revenue in   edaps ablatherm® robotic hifu clinical results support highintensity focused ultrasound hifu for prostate tissue ablatio  edap tms sa to report fourth quarter and full year  results on april    edaps long term academic hifu partner inserm labtau designated center of excellence by the focused ultrasound foundation  edap appoints vicepresident of global medical regulatory and quality affairs in the us there are currently no press releases for this ticker please check back later profile edap tms sa designs and manufactures medical equipment the company develops minimally invasive therapeutic ultrasound solutions for urology tumor removal localized prostate cancer and infectious diseases edap tms serves patients and medical professionals worldwide address  rue du dauphinepa la poudrette lamartinevaulxenvelin france phone  website wwwedaptechnomedcom executives board members marc oczachowski chief executive officer francois dietsch chief financial officer noah j bartsch vpglobal medical show more edap tms  withdraws us marketing application for focal one resubmission planned with new clinical data  traders log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east� more equities indexes dow jonessp nasdaq tsx compftse � more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd� more currencies commodities goldcrude oil wticrude oil brentsilverplatinum� more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    equities    nasdaq    edap tms sa    edap edap tms sa edap add to my list    mes derni�res consultmost popular manage my lists  delayed     pm  usd     edap to host webcast discussing hifu devices with an american key  edap tms  withdraws us marketing application for focal one resub  edap tms  announces withdrawal of k application for focal one  summaryquoteschartsnewscompany news summarymost relevantall newssector newstweets edap tms  withdraws us marketing application for focal one resubmission planned with new clinical data    pm cest send by mail  last name  name  from  to  you can enter multiple email addresses separated by commas message  required fields edap tms sa nasdaqedap has withdrawn its us k application for its focal one device after discussions with the fda it plans to file another application with new clinical data ceo marc oczachowski says as mentioned during our last quarterly call a shift in biopsy protocol has created difficulties in comparing biopsy data under the current k application we actively worked with some of our key users in europe to gather new and additional clinical data on focal one in order to provide them to the agency for review it is not possible to include this new clinical data in our current file under review and thus need to withdraw our current application and submit a new k with the new set of clinical data which will be filed very soon focal one is a robotassisted highintensity focused ultrasound hifu system used to for focal therapy for prostate cancerc  tbreak media all rights reserved provided by syndigate media inc syndigateinfo source middle east  north african newspapers  latest news on edap tms sa  edap to host webcast discussing hifu devices with an american key opinion lea  edap tms  withdraws us marketing application for focal one resubmission plan  edap tms  announces withdrawal of k application for focal one to be follow  edap announces withdrawal of k application for focal one� to be followed  edap announces cms approval of new reimbursement code for hifu ablation of th  edap tms sa reports first quarter  results  edap announces ablatherm fusion world premiere during american urology associ  edap tms sa to report first quarter  financial results on may    edap achieves  growth in hifu revenue in   edaps ablatherm��robotic hifu  clinical results support highintensity focused more news news from seekingalpha  edap withdraws us marketing application for focal one resubmission planned  midday gainers  losers  midday gainers  losers  us reimbursement outlook for edaps hifu in prostate cancer improves with e  healthcare  top  gainers  losers   am chart edap tms sa duration  auto  months  months  months  months  year  years  years  years max period  day week fullscreen chart sector and competitors st jancapitalization m edap tms sa thermo fisher scientific inc  danaher  boston scientific corporation  intuitive surgical  royal philips  more results traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners b�rse aktien kurse und nachrichtenbest tweets copyright �  surperformance all rights reserved slave edap tms sa edap  product pipeline analysis trends share size research report uscanada toll free home globaldata surgical equipment edap tms sa edap  product pipeline analysis edap tms sa edap  product pipeline analysis published by  globaldata published date  nov  category  surgical equipment no of pages   pages description table of content check discount edap tms sa edap is a medical equipment company it carries out the development production marketing and distribution of minimally invasive medical devices that are used in the treatment of urological diseases the company offers its products and services through its two divisions namely high intensity focused ultrasound hifu and urology devices and services uds its major products include ablatherm hifu minimallyinvasive treatment for localized prostate cancer and sonolith extracorporeal shockwave lithotripters eswl the company also offers services such as mobile services for hifu and lithotripters training centers and after sales services edaps products are utilized by large hospitals urology clinics and research institutions it has subsidiaries in italy germany russia the us japan korea and malaysia the company markets its products through its own sales force as well as through a network of distributors and agents edap is headquartered in vaulxenvelin france the company seeks to capitalize on its expertise in eswl and its position in urology to achieve longterm growth edaps strategy is to apply hifu technology toward the minimally invasive treatment of other medical conditions beyond prostate cancer this report is a source for data analysis and actionable intelligence on the edap tms sa portfolio of pipeline products the report provides detailed analysis on each pipeline product with information on the indication the development stage trial phase product milestones pipeline territory estimated approval date and estimated launch date each pipeline product is profiled to cover information on product description function technology indication and application the report is also supplemented with a detailed company profile and information on clinical trials wherever applicable this report is built using data and information sourced from proprietary databases primary and secondary research and inhouse analysis by globaldatas team of industry experts scope detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments detailed coverage on all the pipeline products by equipment type by therapy area by development stage and by trial phase information on product milestones and pipeline territory for each product the estimated approval date and estimated launch date profile of each pipeline product with additional information on product description function technology indications and application data on relevant clinical trials and product patent details wherever applicable information on clinical trial wherever applicable is supplemented with information on trial phase trial status trial objective trial design target patients unique physician identifier primary point secondary point acronym participants inclusion participants exclusion interventions trial results trial start date trial end date study type trial site trial funding age eligibility and gender eligibility reasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally design and develop your product development marketing and sales strategies exploit ma opportunities by identifying market players with the most innovative pipeline develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials stage and phase of development etcwhich are the next highvalue products that your competitor would add in its portfolio identify understand and capitalize table of content table of contents list of tables list of figures  edap tms sa  business description  key facts edap tms sa  major products and services edap tms sa pipeline products by equipment type edap tms sa pipeline products by development stage edap tms sa pipeline products by therapy area edap tms sa pipeline products by trial phase edap tms sa pipeline products by milestone summary ablatherm hifu device  prostate cancer ablatherm hifu device  prostate cancer product status ablatherm hifu device  prostate cancer product description ablatherm hifu device  prostate cancer product milestone ablatherm hifu device  prostate cancer clinical trial ablatherm hifu device  prostate cancer product patent details hifu system  liver cancer hifu system  liver cancer product status hifu system  liver cancer product description hifu system  liver cancer product milestone hifu triggered drug delivery system hifu triggered drug delivery system product status hifu triggered drug delivery system product description edap tms sa  key competitors edap tms sa  key employees edap tms sa  key employee biographies edap tms sa  locations and subsidiaries head office other locations  subsidiaries recent developments edap tms sa recent developments nov   edap reports revenue of m in q  aug   edap reports revenue of m in q  jun   edap highlights hifu technology at istu  may   edap reports revenue of m in q  mar   edap reports revenue of m in  dec   edap presents ablathermhifu and renewed lithotripsy product line at two scientific conferences nov   edap reports revenues of m in q  oct   edap reports preliminary q  results aug   edap reports total revenues of m in q  aug   edap partnership wins m grant for development of imaging solution for focal treatment of prostate cancer  appendix methodology about globaldata contact us disclaimer  list of table edap tms sa key facts edap tms sa key pipeline products by equipment type edap tms sa key pipeline products by therapy area edap tms sa key pipeline products by development stage edap tms sa key pipeline products by trial phase edap tms sa key facts edap tms sa major products and services edap tms sa number of pipeline products by equipment type edap tms sa pipeline products by equipment type edap tms sa number of pipeline products by development stage edap tms sa pipeline products by development stage edap tms sa number of pipeline products by therapy area edap tms sa pipeline products by therapy area edap tms sa number of pipeline products by trial phase edap tms sa pipeline products by trial phase edap tms sa number of pipeline products by milestone summary edap tms sa pipeline products by milestone summary ablatherm hifu device  prostate cancer  product status ablatherm hifu device  prostate cancer  product description ablatherm hifu device  prostate cancer  product milestone ablatherm hifu device  prostate cancer  ablatherm integrated imaging high intensity focused ultrasound for the indication of low risk localized prostate cancer ablatherm hifu device  prostate cancer  evaluation of the ablatherm high intensity focused ultrasound device after failed radiation therapy for localized prostate cancer ablatherm hifu device  prostate cancer  enlight ablatherm hifu device  prostate cancer  patent details ablatherm hifu device  prostate cancer  patent details ablatherm hifu device  prostate cancer  patent details ablatherm hifu device  prostate cancer  patent details hifu system  liver cancer  product status hifu system  liver cancer  product description hifu system  liver cancer  product milestone hifu triggered drug delivery system  product status hifu triggered drug delivery system  product description edap tms sa key employees edap tms sa key employee biographies edap tms sa subsidiaries  list of chart edap tms sa key pipeline products by equipment type edap tms sa pipeline products by equipment type edap tms sa pipeline products by development stage edap tms sa pipeline products by therapy area edap tms sa pipeline products by trial phase edap tms sa pipeline products by milestone summary  make an enquiry before buying this report please fill the enquiry form below full name  your email  job title  company  phone no  pls affix country code message security code   choose license type  select user license single license user  multiple license user  do you wish to check sample of this report order a sample report have query on this report related news grab gets us bn funding from didi and softbank google street view introduces international space station view zinc prices to continue to shoot as hopes of output rise remain bleak shift to cloudbased products and services fares well for microsoft india remains leading provider of online labors in technology and software development sector research assistance we will be happy to help you find what you need please call us or write to us  uscanada toll free tel   email  salesresearchmozus edap tms s a expands product portfolio with new urological stone laser employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       edap tms sa edap expands product portfolio with new urological stone laser tweet   am lyon france feb   globe newswire  edap tms sa nasdaqedap the global leader in therapeutic ultrasound today announced a multinational strategic oem partnership with quanta system a leading manufacturer of medical lasers for surgical and other applications under the agreement quanta will manufacture customized urological stone lasers to be sold under the edap brand additionally edap will continue to distribute holmium lasers in france and certain north african territories pursuant to its exclusive agreement with lumenis in those regions marc oczachowski edaps chief executive officer commented the addition of urological stone lasers to edaps product portfolio will provide excellent synergy with our existing lithotripsy offering for the treatment of urinary stones we are excited to partner with quanta system the world leader in development and manufacture of stone lasers to bring their cuttingedge technology to urologists and patients and drive incremental growth for our company this strategic partnership enables edap to offer a complete range of minimally invasive solutions from intracorporeal lithotripsy lasers to extracorporeal shockwave lithotripsy devices covering the full scope of urinary tract stone indications oczachowski continued with our wellestablished worldwide network of fullyowned subsidiaries dedicated distributors and partners we are well positioned to maximize our lithotripsy sales activity going forward paolo salvadeo quanta systems chief executive officer commented we are very happy to partner with edap as this new cooperation strengthens our position in the worldwide urology market where quanta already enjoys strong market share in laser lithotripsy our core solutions for urinary stones represent a real benchmark for the industry and we are pleased to offer them to edap a dynamic company that shares many similarities with quanta and to contribute to their continued success throughout the world about edap tms sa edap tms sa markets today ablatherm® for highintensity focused ultrasound hifu treatment of localized prostate cancer hifu treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects ablathermhifu is generally recommended for patients with localized prostate cancer stages tt who are not candidates for surgery or who prefer an alternative option or for patients who failed radiotherapy treatment ablathermhifu is approved and commercialized in europe as a treatment for prostate cancer and is currently under regulatory review in the us following submission of the premarket approval application in february  after the completion of a multicenter us phase iiiii clinical trial under an investigational device exemption ide granted by the fda in march  the company introduced a new innovative hifu device the focal one® dedicated to focal therapy of prostate cancer focal one® is ce marked but is not fda approved the company also develops its hifu technology for the potential treatment of certain other types of tumors edap tms sa also produces and commercializes medical equipment the sonolith® range for treatment of urinary tract stones using extracorporeal shockwave lithotripsy eswl for more information on the company please visit httpwwwedaptmscom and httpwwwhifuplanetcom about quanta system spa quanta system spa produces lasers and laser systems for a wide range of scientific medical and industrial applications quanta system spa was founded in  today with over twenty years of experience in the design of laser sources laser systems and specific solutions for the oem market it is a global company founded on a myriad of local expertise italian creativity and research the methodology and tradition of the german optics industry americanstyle oriented marketing and the successful spanish distribution model for more information on quanta system please visit httpwwwquantasystemcom forwardlooking statements in addition to historical information this press release may contain forwardlooking statements such statements are based on managements current expectations and are subject to a number of risks and uncertainties including matters not yet known to us or not currently considered material by us and there can be no assurance that anticipated events will occur or that the objectives set out will actually be achieved important factors that could cause actual results to differ materially from the results anticipated in the forwardlooking statements include among others the uncertainties of the us fda approval process the clinical status and market acceptance of our hifu devices and the continued market potential for our lithotripsy device factors that may cause such a difference also may include but are not limited to those described in the companys filings with the securities and exchange commission and in particular in the sections cautionary statement on forwardlooking information and risk factors in the companys annual report on form f ablathermhifu treatment is in clinical trials but not fdaapproved or marketed in the united states contact blandine confort investor relations  legal affairs edap tms sa       bconfortedaptmscom investors lee roth the ruth group  lroththeruthgroupcom help employers find you check out all the jobs and post your resume read at biospacecom related news edap tms sa edaps focal one hifu device approved by health canada brainaltering devices may supplant drugs—and pharma is ok with that edap tms sa edap receives fda guidance on pma for ablathermhifu raumedic to bring  new jobs to north carolina edap tms sa edap reports continued strong growth in third quarter  bayer ag bayzf to decide in second half on ipo or spinoff for plastics unit shareholders sue edap tms sa edap following fda slip  steps to medical device clinical outsourcing success edap tms sa edap to report third quarter  results on november   ann arbor’s warmilu hopes to save preemies with hightech blankets please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • edap tms sa   • medical devices • medical dev  diag  product news                 edap tms sa edapo company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile edap tms sa edapo related topics stocksstock screenerhealthcareadvanced medical equipment  technology overview news key developments people charts financials analysts research pulse edapo on consolidated issue listed on nasdaq global market usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description edap tms sa edap incorporated on april   is a holding company engaged in developing and marketing the ablatherm and focal one devices the company operates two divisions high intensity focused ultrasound hifu and urology devices and services uds including lithotripsy activities it offers products for hifu treatment of localized prostate cancer through these two divisions the company develops produces and markets medical devices mainly for urological diseases the companys hifu and uds divisions operate in europe the americas asia and the rest of the world the company is developing hifu technology for the treatment of certain other types of tumors the company also produces and commercializes medical equipment for treatment of urinary tract stones using extracorporeal shockwave lithotripsy eswl and distributes other types of urology devices in certain countrieshigh intensity focused ultrasound divisionthe companys hifu division is engaged in the development manufacturing and marketing of medical devices based on hifu technology for the invasive treatment of urological and other clinical indications hifu technology uses a highintensity convergent ultrasound beam generated by high power transducers to produce heat hifu technology is intended to allow the surgeon to destroy a welldefined area of diseased tissue without damaging surrounding tissue and organs thereby eliminating the need for incisions transfusions and general anesthesia and associated complications the companys hifu division markets two hifu devices the ablatherm and the focal one the ablatherm is used for the treatment of organconfined prostate cancer referred to as tt stage ablatherm is approved for commercial distribution in the european union the united states south korea canada australia taiwan south africa new zealand the philippines argentina mexico brazil russia venezuela peru and ecuador hifu division also produces and markets the focal one device a hifu robotic device for the focal therapy of localized prostate cancer thereby destroying focused cancer cells only focal one is approved for commercial distribution in the european union canada saudi arabia south korea peru and chile the companys hifu division has an installed base of approximately  ablatherm machines over  focal one and approximately  trained clinical sites across the world were using this technology in addition the hifu division is also engaged in leasing equipment as well as the sale of disposables spare parts and maintenance services the companys hifu mobile treatment option provides access to the hifu devices without requiring hospitals and clinics to make an upfront investment in the equipment instead hospitals and clinics perform treatments using these devicesthe company competes with sonacare medical general electric theraclion elbit medical imaging haifu and philips healthcareurology devices and services divisionthe companys uds division is engaged in the development marketing manufacturing and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders urinary stones and other clinical indications the companys uds divisions primary business is producing and marketing devices known as lithotripters for the treatment of urinary tract stones by means of eswl technology the uds division manufactures two models of lithotripters the sonolith imove and the sonolith isys the uds division sells over  eswl lithotripters across the world and maintains otherwise serviced  installed lithotripters the company is also engaged in the leasing of lithotripters as well as the sale of disposables spare parts and maintenance services the company manufactures its own products as part of edap tms france sas its subsidiary the company offers the sonolith imove to small and midsize hospitals while the sonolith isys is offered to large hospitals the uds division also sells disposable parts for lithotripters including the piezoelectric elements of the lt and the electrodes of the sonolith line the sonolith imove is available for commercial distribution in the european union south korea malaysia peru venezuela colombia costa rica japan the united states taiwan singapore saudi arabia mexico and brazil the sonolith isys is available in the european union south korea canada the united states peru colombia argentina venezuela mexico costa rica japan australia malaysia singapore saudi arabia and taiwan the company distributes urodynamic products on behalf of medical measurement systems mms and andromeda in japan and laser urology solutions from lumenis in francethe company competes with siemens storz and dornier » full overview of edapo company address edap tms sa parc activitela poudrette lamartine rue du dauphinevaulxenvelin      p f  company web links home page officers  directors name compensation philippe chauveau  marc oczachowski  pierre beysson  robrecht michiels  argil wheelock  » more officers  directors edap tms sa news briefedap tms sa reports q earnings per share eur  may   briefzenicor medical systems signs partnership deal with technomed may   briefedap sees q  revenue  million euro feb   » more edapo news related topics stocksstock screenerhealthcareadvanced medical equipment  technology market report edap tms sa edap  product pipeline analysis  update about us • publishers • contact us • cart login  register all industries business  finance  business  financial services  insurance  marketing consumer  food  beverages  consumer goods  food  retailing healthcare  biotechnology  healthcare  medical devices  pharmaceuticals heavy industry  construction  energy  manufacturing  materials  transportation internet  media  ebusiness  internet  media  publishing public sector  defense  education  government telecom  computing  computer technology  fixed networks  software  wireless companycountry reports  company reports  country reports  regional reports   processing edap tms sa edap  product pipeline analysis  update sep    globaldata   pages  usd  click here to open the popup youve added the following report to your cartclose cart summary total items subtotal      report summary table of contents request details related edap tms sa edap is a medical device company it carries out the development production and distribution of minimally invasive medical devices for the treatment of urological diseases the company offers its products and services through its two divisions high intensity focused ultrasound hifuand urology devices and services uds some of its products include ablatherm hifu minimallyinvasive treatment for localized prostate cancerand sonolith extracorporeal shockwave lithotripters eswl the company also offers mobile services for hifu and lithotripters its products find applications in hospitals urology clinics and research institutions the sells its products through direct sales force and distributors in the us france italy germany japan south korea malaysia and through representative office in uae the company operates through its subsidiaries located in americas europe middleeastafrica asia and australianew zealand edap is headquartered in vaulxenvelin francethis report is a source for data analysis and actionable intelligence on the companys portfolio of pipeline products the report provides key information about the company its major products and brandsthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescopethe report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developmentsthe report analyzes all pipeline products in development for the company edap tms sathe report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial statusthe report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch datethe report provides detailed description of products in development technical specification and functionsthe report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buydevelop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscapedesign and develop your product development marketing and sales strategies by understanding the competitor portfolioto formulate effective research  development strategiesdevelop marketentry and market expansion strategiesexploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust returnplan mergers and acquisitions effectively by identifying key players of the most promising pipelineidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantagedevelop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials stage and of development etcidentify understand and capitalize the next highvalue products that your competitor would add in its portfolio table of contentstable of contentslist of tableslist of figuresedap tms sa company snapshotedap tms sa company overviewkey informationedap tms sa pipeline products and clinical trials overviewedap tms sa  pipeline analysis overviewbusiness descriptionkey factsedap tms sa  major products and servicesedap tms sa pipeline products by development stageedap tms sa pipeline products overviewablatherm hifu device  prostate cancerablatherm hifu device  prostate cancer product overviewhifu system  liver cancerhifu system  liver cancer product overviewhifu triggered drug delivery systemhifu triggered drug delivery system product overviewedap tms sa  key competitorsedap tms sa  key employeesedap tms sa  key employee biographiesedap tms sa  locations and subsidiarieshead officeother locations  subsidiariesrecent developmentsedap tms sa recent developmentsaug   edap reports strong yearoveryear revenue growth in second quarteraug   edap provides formal response to fda addressing all concerns raised in july  ablatherm hifu letterjul   edap receives feedback from fda on direct de novo k petition for ablatherm hifujul   edap names francois dietsch chief financial officerjul   edaps focal one hifu device adopted by two university hospitals in switzerlandjul   edap announces senior management transitionjun   edap announces focal one hifu installation at germanys martiniklinikmay   edap reports first quarter  resultsapr   edap reports fourth quarter and full year  resultsmar   edap announces sale of first focal one hifu device in north americaappendixmethodologyabout globaldatacontact usdisclaimerlist of tablesedap tms sa key factsedap tms sa pipeline products and clinical trials overviewedap tms sa pipeline products by equipment typeedap tms sa pipeline products by indicationedap tms sa key factsedap tms sa major products and servicesedap tms sa number of pipeline products by development stageedap tms sa pipeline products summary by development stageablatherm hifu device  prostate cancer  product statusablatherm hifu device  prostate cancer  product descriptionhifu system  liver cancer  product statushifu system  liver cancer  product descriptionhifu triggered drug delivery system  product statushifu triggered drug delivery system  product descriptionedap tms sa key employeesedap tms sa key employee biographiesedap tms sa subsidiarieslist of figuresedap tms sa pipeline products by equipment typeedap tms sa pipeline products by development stage this report does not have a list of companies mentioned available this report does not have a press release associated with it order today format pdf  usd license single user delivery by email   business day the fast market research advantage only the best all of our research is sourced from the most trusted and established global analysts and consultancies client focused from startups to multinationals we focus on providing the right research to our diverse client base shop securely our usbased customer service team and ecommerce systems adhere to the highest data security standards industryleading customer support individualized assistance from our expert staff is never more than an email or phone call away best price guarantee we are committed to providing the best research at the lowest cost we will match any published price for the same report guaranteed easy ordering once you’ve found the right report click ‘order now’ and complete the checkout process using any major credit card check or wirebank transferneed multiuser or enterprise license pricing contact us for a custom quote about the publisher globaldata is a leading provider of global business intelligence including market competitor product and customer information it provides indepth research analysis data and forecasts through a range of interactive online databases reports and management briefings globaldata has a large team of experienced research and analysis consulting and marketing experts it has a global presence including key offices in the us europe and asia the group has over  years of experience of delivering market intelligence data and analysis and a highly experienced senior management team publisher details privacy policy  terms of use  flashalerts copyright copy  fast market research inc